ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Experimental drug that builds muscle
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Jinzang" data-source="post: 44787" data-attributes="member: 12925"><p>Here is the page describing TT401 from Transition Therapeutics. It's being marketed as a treatment for Type 2 Diabetes.</p><p></p><p>The fastest growing segment of the diabetes market is the class of GLP-1 single-agonist therapies. TT401, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity, is a dual agonist of the GLP-1 (Glucagon-Like Peptide-1) and glucagon receptors. These receptors play an integral role in regulating appetite, food intake, satiety and energy utilization in the body. Stimulating both these receptors, TT401 has the potential to regulate blood glucose levels with important additional outcomes, such as weight loss.</p><p></p><p>Doesn't sound like it binds to androgen receptors, so don't see how it's a SARM.</p><p></p><p><a href="http://www.transitiontherapeutics.com/technology/tt401.php" target="_blank">http://www.transitiontherapeutics.com/technology/tt401.php</a></p></blockquote><p></p>
[QUOTE="Jinzang, post: 44787, member: 12925"] Here is the page describing TT401 from Transition Therapeutics. It's being marketed as a treatment for Type 2 Diabetes. The fastest growing segment of the diabetes market is the class of GLP-1 single-agonist therapies. TT401, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity, is a dual agonist of the GLP-1 (Glucagon-Like Peptide-1) and glucagon receptors. These receptors play an integral role in regulating appetite, food intake, satiety and energy utilization in the body. Stimulating both these receptors, TT401 has the potential to regulate blood glucose levels with important additional outcomes, such as weight loss. Doesn't sound like it binds to androgen receptors, so don't see how it's a SARM. [url]http://www.transitiontherapeutics.com/technology/tt401.php[/url] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Experimental drug that builds muscle
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top